Development and Validation of Enzyme-Linked Immunosorbent Assay for Group B Streptococcal Polysaccharide Vaccine

Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of neonatal sepsis and meningitis in infants. Limitations of prenatal GBS screening and intrapartum antibiotic prophylaxis render developing GBS vaccines a high priority. In this study, we developed an enzyme-linked immunosorbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, A-Yeung, Choi, Min-Joo, Zhi, Yong, Ji, Hyun-Jung, Noh, Ji-Yun, Yoon, Jin-Gu, Cheong, Hee-Jin, Kim, Woo-Joo, Seo, Ho-Seong, Song, Joon-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224333/
https://www.ncbi.nlm.nih.gov/pubmed/34064299
http://dx.doi.org/10.3390/vaccines9060545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224333/
https://www.ncbi.nlm.nih.gov/pubmed/34064299
http://dx.doi.org/10.3390/vaccines9060545

Ejemplares similares